Exemption to enable timely access to radiopharmaceuticals and RAI
Information on an exemption for radiopharmaceuticals that facilitates interstate supply during COVID-19.
Published
Related content
-
Ventilators for COVID-19 use in Australia
This specification describes the minimal acceptable performance and desired features for a ventilator to be used in Australian hospitals during the current SARS-CoV2 outbreak. -
Australia's first COVID treatment approved
The TGA has granted provisional approval to remdesivir ("Veklury", Gilead Sciences Pty Ltd) as the first treatment option for COVID-19. -
Promotion of COVID-19 vaccinations: further information for healthcare practitioners and other advertisers
Interaction between TGA and AHPRA advertising guidelines